Biotech

All Articles

Roche is carrying out chances that its injectable being overweight prospect might eventually show 25% weight loss in late-stage test

.Roche is keeping out chances that its injectable excessive weight prospect might ultimately illustr...

Novo Nordisk barrages 'impressive' weight loss lead for dual-acting oral drug in very early trial

.Novo Nordisk has elevated the top on a phase 1 trial of its oral amylin and GLP-1 receptor co-agoni...

AbbVie files suit BeiGene over blood cancer cells drug secret method

.Just a couple of quick weeks after succeeding an FDA Fast Track tag for its own investigational BTK...

Lilly delivers one-two strike along with second tranche of favorable data on weekly the hormone insulin prospect

.Quickly after a good information decrease for Eli Lilly's efsitora alfa, the Indianapolis-based bus...

BridgeBio cuts gene treatment budget plan as clinical data disappoint

.BridgeBio Pharma is actually slashing its own gene therapy spending plan and pulling back from the ...

GSK surrenders HSV vaccination wishes after phase 2 fail, yielding ethnicity to Moderna, BioNTech

.GSK's try to develop the very first injection for genital herpes simplex infection (HSV) has actual...

GSK's long-acting breathing problem medicine cut in half assaults in phase 3

.GSK's long-acting asthma procedure has actually been revealed to halve the amount of assaults in a ...

AstraZeneca, Daiichi unload Dato-DXd's total survival stop working

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually fallen s...

Roivant introduces brand new 'vant' to advance Bayer hypertension med

.Matt Gline is actually back with a brand new 'vant' provider, after the Roivant Sciences chief exec...

Viridian eye disease stage 3 smash hits, evolving push to rival Amgen

.Viridian Therapeutics' period 3 thyroid eye condition (TED) medical test has reached its main and s...